BG106404A - Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване - Google Patents
Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаванеInfo
- Publication number
- BG106404A BG106404A BG06404A BG10640402A BG106404A BG 106404 A BG106404 A BG 106404A BG 06404 A BG06404 A BG 06404A BG 10640402 A BG10640402 A BG 10640402A BG 106404 A BG106404 A BG 106404A
- Authority
- BG
- Bulgaria
- Prior art keywords
- weight
- ciprofloxacin
- pharmaceutical composition
- contaning
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title abstract 5
- 229960003405 ciprofloxacin Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920002774 Maltodextrin Polymers 0.000 abstract 1
- 239000005913 Maltodextrin Substances 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 229940035034 maltodextrin Drugs 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретението се отнася до фармацевтичен състав снезабавно освобождаване, съдържащ в тегл.% следните компоненти: от 60 до 80 ципрофлоксацин под формата на ципрофлоксацин хидрохлорид монохидрат, от 2до 10 малтодекстрин, от 5 до 15 разпадащо веществоот вида карбоксиметил нишесте, от 3 до 6 силициевдиоксид, 1-3 мазилно вещество, а в таблетки, покрити с филм, от 2 до 6 слой на филмово покритие.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9902725A HU227070B1 (en) | 1999-08-11 | 1999-08-11 | Immediate release pharmaceutical composition containing ciprofloxacin and process for its production |
PCT/HU2000/000090 WO2001012162A1 (en) | 1999-08-11 | 2000-08-11 | Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106404A true BG106404A (bg) | 2002-09-30 |
Family
ID=89999030
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG06404A Pending BG106404A (bg) | 1999-08-11 | 2002-02-01 | Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1207857B1 (bg) |
AT (1) | ATE241967T1 (bg) |
AU (1) | AU6716100A (bg) |
BG (1) | BG106404A (bg) |
CZ (1) | CZ2002505A3 (bg) |
DE (1) | DE60003196T2 (bg) |
HK (1) | HK1046234B (bg) |
HU (1) | HU227070B1 (bg) |
PL (1) | PL352331A1 (bg) |
RU (1) | RU2251420C2 (bg) |
SK (1) | SK285236B6 (bg) |
UA (1) | UA72270C2 (bg) |
WO (1) | WO2001012162A1 (bg) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
DE602006012962D1 (de) * | 2006-07-19 | 2010-04-29 | Tabuk Pharmaceutical Mfg Co | Pharmazeutische Zubereitungen von Ciprofloxacin |
CN107669645A (zh) * | 2017-10-31 | 2018-02-09 | 瑞阳制药有限公司 | 盐酸环丙沙星片的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3601566A1 (de) * | 1986-01-21 | 1987-07-23 | Bayer Ag | Pharmazeutische zubereitungen von ciprofloxacin |
US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
ATE197900T1 (de) * | 1996-08-15 | 2000-12-15 | Losan Pharma Gmbh | Gut schluckbare orale arzneiform |
-
1999
- 1999-08-11 HU HU9902725A patent/HU227070B1/hu not_active IP Right Cessation
-
2000
- 2000-08-11 EP EP00954808A patent/EP1207857B1/en not_active Expired - Lifetime
- 2000-08-11 WO PCT/HU2000/000090 patent/WO2001012162A1/en active IP Right Grant
- 2000-08-11 AT AT00954808T patent/ATE241967T1/de not_active IP Right Cessation
- 2000-08-11 PL PL00352331A patent/PL352331A1/xx unknown
- 2000-08-11 SK SK213-2002A patent/SK285236B6/sk unknown
- 2000-08-11 RU RU2002106727/15A patent/RU2251420C2/ru not_active IP Right Cessation
- 2000-08-11 CZ CZ2002505A patent/CZ2002505A3/cs unknown
- 2000-08-11 DE DE60003196T patent/DE60003196T2/de not_active Expired - Fee Related
- 2000-08-11 AU AU67161/00A patent/AU6716100A/en not_active Abandoned
- 2000-11-08 UA UA2002031867A patent/UA72270C2/uk unknown
-
2002
- 2002-02-01 BG BG06404A patent/BG106404A/bg active Pending
- 2002-08-07 HK HK02105791.8A patent/HK1046234B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU6716100A (en) | 2001-03-13 |
SK285236B6 (sk) | 2006-09-07 |
UA72270C2 (en) | 2005-02-15 |
PL352331A1 (en) | 2003-08-11 |
CZ2002505A3 (cs) | 2002-06-12 |
DE60003196T2 (de) | 2004-04-29 |
HK1046234A1 (en) | 2003-01-03 |
RU2251420C2 (ru) | 2005-05-10 |
DE60003196D1 (de) | 2003-07-10 |
SK2132002A3 (en) | 2002-08-06 |
HK1046234B (zh) | 2004-03-19 |
HUP9902725A2 (hu) | 2001-12-28 |
EP1207857B1 (en) | 2003-06-04 |
RU2002106727A (ru) | 2004-01-10 |
HU227070B1 (en) | 2010-06-28 |
HU9902725D0 (en) | 1999-10-28 |
ATE241967T1 (de) | 2003-06-15 |
WO2001012162A1 (en) | 2001-02-22 |
EP1207857A1 (en) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2367136A1 (en) | Use of xenon for treating neurointoxications | |
TW340045B (en) | Extended zero order release pharmaceutical composition | |
BR9810984A (pt) | Composto de triazol, uso do mesmo, e, composição farmacêutica | |
IL125848A0 (en) | New compositions containing copidogrel and an antithrombotic agent | |
IL133623A0 (en) | Antithrombotic agents | |
IL133627A0 (en) | Antithrombotic agents | |
IL115357A (en) | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols | |
IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
HUP9601564A2 (hu) | Irbesartant tartalmazó gyógyszerkészítmények | |
WO2004012699A3 (en) | Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent | |
WO2007048219A3 (en) | Sustained drug release composition | |
GR3031135T3 (en) | Compositions containing S(+)-Ibuprofen. | |
GR3037080T3 (en) | Naphthalene derivatives as prostaglandin i2 agonists | |
IL114599A (en) | Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them | |
CY2469B1 (en) | Pharmaceutical compositions for sustained release of the hmg-coa reductase inhibitor fluvastatin. | |
NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
ATE155039T1 (de) | Mit zucker überzogene pharmazeutische dosierungseinheit | |
CA2325739A1 (en) | Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator | |
BG105257A (bg) | Нови орални състави за агонисти или антагонисти на 5-ht долу 4 | |
BG106404A (bg) | Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване | |
NO954952D0 (no) | Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac | |
NZ332655A (en) | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | |
BR9813602A (pt) | Composições farmacêuticas contendo medicamentos bicìclicos micronizados | |
HUP0203226A2 (hu) | Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény | |
NZ523606A (en) | Pharmaceutical compositions and methods for use |